organophosphonates has been researched along with Retinitis in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (78.95) | 18.2507 |
2000's | 3 (15.79) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cinek, O; Formankova, R; Hubacek, P; Keslova, P; Lochmanova, J; Pochop, P; Sedlacek, P; Stary, J; Zajac, M | 1 |
Dutta, A; Edwards, MS; Schwarzwald, HL | 1 |
Mitchell, SM; Obi, AA; Zambarakji, HJ | 1 |
Aldern, K; Beadle, JR; Bessho, K; Bovet, JM; Cheng, L; Freeman, WR; Hostetler, KY; Koh, HJ; Lee, J; Toyoguchi, M | 1 |
Assil, KK; Bergeron-Lynn, G; Besen, G; De Clercq, E; Flores-Aguilar, M; Gangan, P; Kupperman, BD; Munguia, D; Pursley, M; Vuong, C | 1 |
Bergeron-Lynn, G; Chandler, B; De Clercq, E; Flores-Aguilar, M; Freeman, WR; Huang, JS; Munguia, D; Vuong, C; Wiley, CA | 1 |
Assil, KK; Bergeron-Lynn, G; Besen, G; Connor, JD; De Clercq, E; Freeman, WR; Kuppermann, BD; Munguia, D; Pursley, M; Vuong, C; Wiley, CA | 1 |
Jabs, DA | 2 |
Arevalo, JF; Azen, SP; Chavez de la Paz, E; Freeman, WR; Munguia, D; Rahhal, FM | 1 |
Cunningham, ET | 1 |
Davis, JL; Feuer, WJ; Freeman, WR; Leonard, RE; Taskintuna, I; Weinberg, DV | 1 |
Friedberg, DN | 1 |
Blick, G; Garton, T; Hopkins, U; LaGravinese, L | 1 |
Arevalo, JF; Banker, AS; Berry, C; De Clercq, E; Freeman, WR; Ishimoto, B; Munguia, D; Ochabski, R; Rahhal, FM; Taskintuna, I | 1 |
Capparelli, EV; Cundy, KC; Freeman, WR; Rahhal, FM; Taskintuna, I | 1 |
Benson, CA; Deutsch, TA; Dieterich, DT; Drew, WL; Feinberg, J; Friedberg, DN; Griffiths, PD; Hardy, WD; Holland, GN; Jabs, DA; Jacobson, MA; Kessler, HA; Polis, MA; Powderly, WG; Spector, SA; Walmsley, S; Whitley, RJ | 1 |
Bowen, EF; Cherrington, JM; Emery, VC; Griffiths, PD; Johnson, MA; Lamy, PD | 1 |
Cochereau, I; Diraison, MC; Doan, S; Guvenisik, N; Hoang-Xuan, T; Mousalatti, H; Ren, L | 1 |
1 review(s) available for organophosphonates and Retinitis
Article | Year |
---|---|
Cidofovir.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds; Retinitis | 1997 |
18 other study(ies) available for organophosphonates and Retinitis
Article | Year |
---|---|
Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet.
Topics: Adolescent; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Encephalitis, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Organophosphonates; Retinitis; Treatment Outcome | 2009 |
Disseminated bartonellosis presenting as neuroretinitis in a young adult with human immunodeficiency virus infection.
Topics: Adenine; Anti-Bacterial Agents; Anti-HIV Agents; Bartonella; Bartonella Infections; Biopsy; Deoxycytidine; Doxycycline; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Lung; Male; Organophosphonates; Oxazines; Retinitis; Rifampin; Treatment Outcome; Young Adult | 2010 |
Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Retinitis; Vitreous Body | 2002 |
Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Topics: Animals; Antiviral Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cytosine; Drug Delivery Systems; Eye Infections, Viral; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Liposomes; Microfluidics; Organophosphonates; Prodrugs; Rabbits; Retina; Retinitis; Vitreous Body | 2004 |
Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Electroretinography; Eye Infections, Viral; Fundus Oculi; Herpes Simplex; Liposomes; Longitudinal Studies; Organophosphonates; Organophosphorus Compounds; Rabbits; Retinitis | 1995 |
Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Organophosphonates; Organophosphorus Compounds; Rabbits; Retinitis; Time Factors | 1994 |
Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Drug Carriers; Eye Infections, Viral; Herpes Simplex; Herpesvirus 1, Human; Injections; Liposomes; Organophosphonates; Organophosphorus Compounds; Rabbits; Retina; Retinitis; Vitreous Body | 1996 |
Treatment of cytomegalovirus retinitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Routes; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Retinitis | 1996 |
Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Progression; Female; Humans; Injections, Intralesional; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retinitis; Treatment Outcome; Vitreous Body | 1996 |
New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Prognosis; Retinitis | 1997 |
Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis.
Topics: Adult; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovirus Infections; Cytosine; Female; Humans; Injections, Intravenous; Iritis; Male; Middle Aged; Muscle Tonus; Muscular Diseases; Oculomotor Muscles; Organophosphonates; Organophosphorus Compounds; Retinitis; Retrospective Studies | 1997 |
Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Injections, Intravenous; Male; Muscle Tonus; Muscular Diseases; Oculomotor Muscles; Organophosphonates; Organophosphorus Compounds; Retinitis | 1997 |
Successful use of cidofovir in treating AIDS-related cytomegalovirus retinitis, encephalitis, and esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Encephalitis, Viral; Esophagitis; Humans; Male; Organophosphonates; Organophosphorus Compounds; Retinitis | 1997 |
Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anterior Chamber; Antiviral Agents; Aqueous Humor; Cidofovir; Ciliary Body; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Female; Fluorophotometry; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retinitis; Ultrasonography; Vitreous Body | 1997 |
Intravitreal and plasma cidofovir concentrations after intravitreal and intravenous administration in AIDS patients with cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovirus Infections; Cytosine; Humans; Injections; Injections, Intravenous; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Osmolar Concentration; Prospective Studies; Retinitis; Vitreous Body | 1998 |
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Lung Diseases; Nervous System Diseases; Organophosphonates; Organophosphorus Compounds; Retinitis | 1998 |
Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Ganciclovir; Genotype; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Prospective Studies; Retinitis; Viral Load; Viral Proteins | 1999 |
Uveitis in patients treated with intravenous cidofovir.
Topics: Adult; Anti-HIV Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; HIV Seropositivity; Humans; Injections, Intravenous; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retinitis; Retrospective Studies; Uveitis | 1999 |